194 related articles for article (PubMed ID: 11280735)
1. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
[TBL] [Abstract][Full Text] [Related]
2. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
3. Interferon reduces somatic mutation of mitochondrial DNA in liver tissues from chronic viral hepatitis patients.
Nishikawa M; Nishiguchi S; Kioka K; Tamori A; Inoue M
J Viral Hepat; 2005 Sep; 12(5):494-8. PubMed ID: 16108764
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
6. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
Jicai Z; Zongtao Y; Jun L; Haiping L; Jianmin W; Lihua H
Mol Carcinog; 2006 Jul; 45(7):530-6. PubMed ID: 16649250
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
8. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC
Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
Nomoto S; Yamashita K; Koshikawa K; Nakao A; Sidransky D
Clin Cancer Res; 2002 Feb; 8(2):481-7. PubMed ID: 11839667
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
13. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection.
Yuen MF; Lau CS; Lau YL; Wong WM; Cheng CC; Lai CL
Hepatology; 1999 Apr; 29(4):1248-51. PubMed ID: 10094971
[TBL] [Abstract][Full Text] [Related]
14. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
15. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
16. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
17. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
18. Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease.
Ueno Y; Moriyama M; Uchida T; Arakawa Y
Hepatology; 2001 Feb; 33(2):357-62. PubMed ID: 11172337
[TBL] [Abstract][Full Text] [Related]
19. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives.
Chen PJ; Chen DS
Semin Liver Dis; 1999; 19(3):253-62. PubMed ID: 10518305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
